Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.
2.

Gene dosage and Down's syndrome: metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinase.

Elson A, Bernstein Y, Degani H, Levanon D, Ben-Hur H, Groner Y.

Somat Cell Mol Genet. 1992 Mar;18(2):143-61.

PMID:
1533471
3.

Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21.

Annerén KG, Korenberg JR, Epstein CJ.

Hum Genet. 1987 May;76(1):63-5.

PMID:
2952576
4.

Altered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies.

Peled-Kamar M, Degani H, Bendel P, Margalit R, Groner Y.

Brain Res. 1998 Nov 9;810(1-2):138-45.

PMID:
9813288
5.
6.

The primary structure of human liver type phosphofructokinase and its comparison with other types of PFK.

Levanon D, Danciger E, Dafni N, Bernstein Y, Elson A, Moens W, Brandeis M, Groner Y.

DNA. 1989 Dec;8(10):733-43.

PMID:
2533063
8.

Impaired glucose-induced insulin response in transgenic mice overexpressing the L-phosphofructokinase gene.

Knobler H, Weiss Y, Peled M, Groner Y.

Diabetes. 1997 Sep;46(9):1414-8.

PMID:
9287040
9.

Genomic clones of the human liver-type phosphofructokinase.

Levanon D, Danciger E, Dafni N, Groner Y.

Biochem Biophys Res Commun. 1986 Nov 26;141(1):374-80.

PMID:
2948503
11.

Rapid detection of trisomy 21 by homologous gene quantitative PCR (HGQ-PCR).

Lee HH, Chang JG, Lin SP, Chao HT, Yang ML, Ng HT.

Hum Genet. 1997 Mar;99(3):364-7.

PMID:
9050924
12.
13.

Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

Van Keuren M, Drabkin H, Hart I, Harker D, Patterson D, Vora S.

Hum Genet. 1986 Sep;74(1):34-40.

PMID:
2944814
14.

Cell damage by excess CuZnSOD and Down's syndrome.

Groner Y, Elroy-Stein O, Avraham KB, Schickler M, Knobler H, Minc-Golomb D, Bar-Peled O, Yarom R, Rotshenker S.

Biomed Pharmacother. 1994;48(5-6):231-40.

PMID:
7999984
15.

Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.

Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, Sinet PM.

Brain Res. 1991 Jun 28;552(2):198-214.

PMID:
1717112
16.

Dinucleotide repeat polymorphism at the human liver-type 6-phosphofructokinase (PFKL) gene.

Polymeropoulos MH, Rath DS, Xiao H, Merril CR.

Nucleic Acids Res. 1991 May 11;19(9):2517. No abstract available.

17.

Brain and liver targeted overexpression of O6-methylguanine DNA methyltransferase in transgenic mice.

Walter CA, Lu J, Bhakta M, Mitra S, Dunn W, Herbert DC, Weaker FJ, Hoog T, Garza P, Adrian GS, et al.

Carcinogenesis. 1993 Aug;14(8):1537-43.

PMID:
8353838
18.

Structure, distribution, and functional expression of the phosphofructokinase C isozyme.

Gekakis N, Johnson RC, Jerkins A, Mains RE, Sul HS.

J Biol Chem. 1994 Feb 4;269(5):3348-55.

19.

Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles.

Bowman BH, Jansen L, Yang F, Adrian GS, Zhao M, Atherton SS, Buchanan JM, Greene R, Walter C, Herbert DC, Weaker FJ, Chiodo LK, Kagan-Hallet K, Hixson JE.

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12115-9.

Supplemental Content

Support Center